Neurogene Inc.

Q4 2023 13F Holders

Symbol: NGNE
CUSIP: 64135M105
Type: Equity
Class: COM
Num filings: 39
Total reported value, excl. options: $187 M

Compare 2023 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type